Salubris Biotherapeutics Inc

This early-stage trial is testing JK06, a new antibody-based cancer drug, in patients with advanced solid tumors that cannot be surgically removed. Researchers will determine the safest and most effective dose while monitoring how patients respond to treatment. The study involves…

This study is testing an experimental drug called JK07 in people who have both heart failure and high blood pressure in their lungs. About 30 adults will receive the drug to check if it's safe and how their bodies process it. The main goal is to see if JK07 can be tolerated and h…